Morris G E, Jamieson N V, Small J, Evans D B, Calne R
Department of Surgery, Cambridge University Medical School, Addenbrooke's Hospital, UK.
Nephrol Dial Transplant. 1991;6(11):887-92. doi: 10.1093/ndt/6.11.887.
The aim of this study is to analyse whether or not old age alone significantly affects the outcome of patient and graft survival in cadaveric renal transplantation, and thus whether it should be a selection criterion for induction into transplant programmes, given the current shortfall in donor organs in the United Kingdom. Data is presented on all 307 solitary cadaveric renal allografts performed at Addenbrooke's Hospital, Cambridge between January 1983 and December 1987. Patients are divided into those aged less than 60 years (n = 243) and those aged 60 years and over (n = 45) at the time of transplantation. There is no significant difference in graft survival between the two groups (60.3% and 62.2%) at 18-60 months (mean 42 months) post-transplantation. Patient survival in the two groups is significantly different (83% and 64.4%, P less than 0.01) at the same point. Causes of graft loss, death, and end-stage renal failure are analysed. It is suggested that patients aged 60 years and over may require less immunosuppression but that graft loss from rejection in this group has a high associated mortality. We conclude that cadaveric renal transplantation in the elderly should only be undertaken after careful selection, paying particular attention to evidence of cardiovascular disease and full counselling of the risk of death with these patients.
本研究的目的是分析单纯高龄是否会显著影响尸体肾移植患者和移植物存活的结果,进而分析鉴于目前英国供体器官短缺的情况,高龄是否应作为纳入移植项目的选择标准。文中呈现了1983年1月至1987年12月期间在剑桥阿登布鲁克医院进行的307例单尸体肾移植的所有数据。患者被分为移植时年龄小于60岁的患者(n = 243)和年龄60岁及以上的患者(n = 45)。移植后18至60个月(平均42个月)时,两组的移植物存活率无显著差异(分别为60.3%和62.2%)。在同一时间点,两组的患者存活率存在显著差异(分别为83%和64.4%,P < 0.01)。分析了移植物丢失、死亡和终末期肾衰竭的原因。研究表明,60岁及以上的患者可能需要较少的免疫抑制,但该组因排斥反应导致的移植物丢失与较高的死亡率相关。我们得出结论,老年患者的尸体肾移植应在仔细选择后进行,尤其要关注心血管疾病的证据,并对这些患者进行充分的死亡风险咨询。